New era of cardiac stem cell therapy in heart failure

Research output: Contribution to journalArticle

Abstract

Despite of plethora of reports on stem cell transplantation leading to neovascularization in infarct models, whether sustaining clinical benefit in post-myocardial infarction patients is manifested by myocyte repair remains unclear. Cardiac muscle regeneration in adult heart is thought to occur through the mobilization and differentiation of mesenchymal stem cells in bone marrow origin, however, recent studies have suggested that substantial cardiac stem cells may exist in the heart itself, repopulating the damaged cardiac muscle during injury or aging processes. The implications of cardiac stem cells-based myocyte plasticity have recently begun to define in human heart, neither arisen from bone marrow nor circulating precursors. Introduction of cardiac stem cells may improve myocardial function, but several hurdles exist and should be coaxed far beyond the clinical application of cardiac regenerative therapies. On-going investigations may lead to the discovery of mediators of cardiac stem cells migration, proliferation and differentiation that, in turn, might result in the mending of the broken heart after injury.

Original languageEnglish
Pages (from-to)61-69
Number of pages9
JournalRinsho byori. The Japanese journal of clinical pathology
Volume53
Issue number1
Publication statusPublished - 2005
Externally publishedYes

Fingerprint

Cell- and Tissue-Based Therapy
Stem Cells
Heart Failure
Muscle Cells
Myocardium
Bone Marrow
Heart Injuries
Stem Cell Transplantation
Mesenchymal Stromal Cells
Cell Movement
Regeneration
Cell Differentiation
Myocardial Infarction
Cell Proliferation
Wounds and Injuries
Therapeutics

Cite this

New era of cardiac stem cell therapy in heart failure. / Oh, Hidemasa.

In: Rinsho byori. The Japanese journal of clinical pathology, Vol. 53, No. 1, 2005, p. 61-69.

Research output: Contribution to journalArticle

@article{9cfb96d77b55414d944cc19bb4fcad06,
title = "New era of cardiac stem cell therapy in heart failure",
abstract = "Despite of plethora of reports on stem cell transplantation leading to neovascularization in infarct models, whether sustaining clinical benefit in post-myocardial infarction patients is manifested by myocyte repair remains unclear. Cardiac muscle regeneration in adult heart is thought to occur through the mobilization and differentiation of mesenchymal stem cells in bone marrow origin, however, recent studies have suggested that substantial cardiac stem cells may exist in the heart itself, repopulating the damaged cardiac muscle during injury or aging processes. The implications of cardiac stem cells-based myocyte plasticity have recently begun to define in human heart, neither arisen from bone marrow nor circulating precursors. Introduction of cardiac stem cells may improve myocardial function, but several hurdles exist and should be coaxed far beyond the clinical application of cardiac regenerative therapies. On-going investigations may lead to the discovery of mediators of cardiac stem cells migration, proliferation and differentiation that, in turn, might result in the mending of the broken heart after injury.",
author = "Hidemasa Oh",
year = "2005",
language = "English",
volume = "53",
pages = "61--69",
journal = "Rinsho byori. The Japanese journal of clinical pathology",
issn = "0047-1860",
publisher = "Nihon Rinsho Byori Gakkai",
number = "1",

}

TY - JOUR

T1 - New era of cardiac stem cell therapy in heart failure

AU - Oh, Hidemasa

PY - 2005

Y1 - 2005

N2 - Despite of plethora of reports on stem cell transplantation leading to neovascularization in infarct models, whether sustaining clinical benefit in post-myocardial infarction patients is manifested by myocyte repair remains unclear. Cardiac muscle regeneration in adult heart is thought to occur through the mobilization and differentiation of mesenchymal stem cells in bone marrow origin, however, recent studies have suggested that substantial cardiac stem cells may exist in the heart itself, repopulating the damaged cardiac muscle during injury or aging processes. The implications of cardiac stem cells-based myocyte plasticity have recently begun to define in human heart, neither arisen from bone marrow nor circulating precursors. Introduction of cardiac stem cells may improve myocardial function, but several hurdles exist and should be coaxed far beyond the clinical application of cardiac regenerative therapies. On-going investigations may lead to the discovery of mediators of cardiac stem cells migration, proliferation and differentiation that, in turn, might result in the mending of the broken heart after injury.

AB - Despite of plethora of reports on stem cell transplantation leading to neovascularization in infarct models, whether sustaining clinical benefit in post-myocardial infarction patients is manifested by myocyte repair remains unclear. Cardiac muscle regeneration in adult heart is thought to occur through the mobilization and differentiation of mesenchymal stem cells in bone marrow origin, however, recent studies have suggested that substantial cardiac stem cells may exist in the heart itself, repopulating the damaged cardiac muscle during injury or aging processes. The implications of cardiac stem cells-based myocyte plasticity have recently begun to define in human heart, neither arisen from bone marrow nor circulating precursors. Introduction of cardiac stem cells may improve myocardial function, but several hurdles exist and should be coaxed far beyond the clinical application of cardiac regenerative therapies. On-going investigations may lead to the discovery of mediators of cardiac stem cells migration, proliferation and differentiation that, in turn, might result in the mending of the broken heart after injury.

UR - http://www.scopus.com/inward/record.url?scp=14944366018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14944366018&partnerID=8YFLogxK

M3 - Article

C2 - 15724492

AN - SCOPUS:14944366018

VL - 53

SP - 61

EP - 69

JO - Rinsho byori. The Japanese journal of clinical pathology

JF - Rinsho byori. The Japanese journal of clinical pathology

SN - 0047-1860

IS - 1

ER -